[Go to the reading](#read)

[Recovery, in plain words](/)

A handbook for choosing care Plain words: on

[What is it?](/start/)

[Is it real?](/approval/)

[How do I find care?](/care/)

[What will I pay?](/cost/)

[What needs checking?](/safety/)

Read the label and the offer together

# Does a research label make it treatment?

A label can say “research use only” while the surrounding page talks about treating people. Read the whole offer, then bring the exact wording to a clinician.

## Questions to work through

Look beyond the small print.

Food and Drug Administration is the agency’s name, shortened to FDA.

In warning letters reviewed September 26, 2026, FDA told particular sellers they may have broken drug laws. FDA said their products were being promoted as treatments for people, despite the research-only labels.

These letters give FDA’s view of what particular sellers did wrong, rather than a court’s decision.

Notice the treatment claims.

A product’s intended purpose can make it a drug under US law; this was the legal position on September 26, 2026. Promises to treat disease or alter the body’s workings are part of that question.

Ask about reviewed patient information.

Approved medicines have pregnancy information in their FDA-reviewed labels. A compounded or other unapproved product has no pregnancy information reviewed by FDA in that way.

## A lab report answers a narrower question

If an offer points to a test certificate, ask what was tested, what the result actually means and what question it leaves unanswered. Do not turn a narrow test into a treatment claim.

Ask separately about evidence for your recovery goal and about who would assess you and how the visit would happen.

## Bring the wording, not just the product name

Keep a copy of the benefit claim and the research-only statement together. Ask the clinician to explain the mismatch before making a decision.

Keep this thought

A research label is not a patient care plan. Ask what it is being offered to do and whether FDA has approved it.

## Notes for this question

### [FDA: a letter to a seller](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/gram-peptides-721806-03312026)

This letter records FDA’s concerns about one seller at the time it was written. It supplies no final court ruling on research products as a whole.

### [Federal rule: intended use](https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-201/subpart-A/section-201.128)

The rule covers evidence of what a product is meant to do.

### [FDA: limits of review](https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers)

The pregnancy-information point follows from the absence of product approval and review.

[Is it approved?](/approval/)  [When can I pause?](/cautions/)  [What can go wrong?](/safety/)

Words, unpacked

Intended use

What the product is being presented as doing.

Warning letter

A letter saying FDA believes a business may have broken the rules.

[Is it approved?](/approval/) [What is compounding?](/compounding/) [What does research-only mean?](/research/) [How can I read the evidence?](/sources/)

[Read this page as text](/research/index.md)

This is a guide for questioning care offers, never a clinic or a place that supplies medicine.

[Begin here](/)  [What can I ask?](/questions/)  [How can I read the evidence?](/sources/)

[Back to the beginning of this page](#top)